US3984384087 - ADR
NEW YORK, NY - (NewMediaWire) - March 28, 2024 - Kaplan Fox & Kilsheimer LLP is investigating potential claims on behalf of investors who purchased Grifols, S.A. (Nasdaq: GRFS) securities. Click Here to Join the Investigation.
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Grifols S.A. ("Grifols" or the "Company") (NASDAQ: GRFS). Such investors are...
NEW YORK, NY - (NewMediaWire) - March 27, 2024 - Kaplan Fox & Kilsheimer LLP is investigating potential claims on behalf of investors who purchased Grifols, S.A. (Nasdaq: GRFS) securities. Click Here to Join the Investigation.
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
NEW YORK, NY - (NewMediaWire) - March 22, 2024 - Kaplan Fox & Kilsheimer LLP is investigating potential claims on behalf of investors who purchased Grifols, S.A. (Nasdaq: GRFS) securities. Click Here to Join the Investigation.
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Curious about the stocks that are showing activity before the opening bell on Friday?
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Grifols S.A. ("Grifols" or the "Company") (NASDAQ: GRFS). Such investors are...
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Grifols S.A. ("Grifols" or the "Company") (NASDAQ: GRFS). Such investors are...
Top movers in Friday's pre-market session
We're starting the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning!
Activist investors are increasing their holdings in Temenos AG and Grifols, despite recent short seller reports.
In the AdFIrst study, Biotest's fibrinogen concentrate (FC), BT524, met the primary endpoint, demonstrating its effectiveness in treating acquired...
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Grifols S.A. ("Grifols" or the "Company") (NASDAQ: GRFS). Such investors are...
Grifols (GRFS) announces new CEO and other leadership changes as founding family members step down. Read more here.
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Grifols S.A. ("Grifols" or the "Company") (NASDAQ: GRFS). Such investors are...
/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of...
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Grifols S.A. ("Grifols" or the "Company") (NASDAQ: GRFS). Such investors are...
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of...
The European Central Bank has contacted lenders to Grifols (GRFS) regarding their exposure to the troubled drugmaker after concerns on its leverage. Read more here.